Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Stephen Duane Oetgen files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Jason Aaron Roth - $1.68M in ARXS purchases and sales in the last 12 months
- Kevin Scott Perhamus - $1.50M in ARXS purchases and sales in the last 12 months
- Azad Sid Badakhsh - $1.01M in ARXS purchases and sales in the last 12 months
- Ross Bradley Sealfon - $350K in ARXS purchases and sales in the last 12 months
- Patrick E. Allen - $280K in ARXS purchases and sales in the last 12 months
- Ryan Anthony Jankowski - $125K in ARXS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Stephen Duane Oetgen?
Stephen Duane Oetgen is a corporate insider of Arxis, Inc. (ARXS). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Stephen Duane Oetgen last file a Form 4?
The only primary Form 4 on record is dated 21 April 2026.
Has Stephen Duane Oetgen been buying or selling stock?
Recorded transactions: 1 open-market purchase ($700K) and 0 open-market sales across all tracked filings.
